Projects and products

Progetto Hyadrol

Joint diseases (arthrosis in primis) are characterized by degenerative phenomena, originating primarily by cartilage and, over time, involving other components of the joint, and are associated with symptoms like pain, swelling and joint stiffness.

The most affected sites are the loading joints (knee, hip) and small joints (i.e. joints of the hands). Their alteration causes limitations in daily activities, compromising – even heavily- the quality of life.

Quite recently it has been discovered that there is a low grade chronic neuroinflammatory process at the base of these joint disorders.

This process is fuelled by a progressive exhaustion of specific lipidic substances that, in the joint, are naturally produced to facilitate the regular metabolism.

With Hyadrol Project, Epitech Group intends to engage in the management of the control over the neuroinflammatory process that sustains joint degenerative diseases, to safeguard the quality of life of those who suffer from it.

Visit the dedicated website for more information: www.hyadrol.it

Read more: hyadrol.it



The access to the web site and to its content is only for personal use and purposes (i.e. for personal information, research or study).
Without prejudice to any right, faculty or authority of third parties, in case of prohibited conduct Epitech Group SpA shall reserve the right to act according to the law.


EPITECH Group SpA unipersonale - Via Egadi, 7 - 20144 Milan Italy - VAT n° 03630550287